For research teamsHelp me find a study
Back to all studies
CompletedNCT00071721

A study of Valproate to Attenuate the Progression of Alzheimer's Disease (AD)

This study is completed in the United States. It is testing valproate for Alzheimer Disease.

Schizophrenia, Alzheimer DiseaseDrugFrom 55 Years to 90 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Valproate may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive Valproate, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateOctober 2003
Recruitment status
Completed
Enrollment listed in the registry
313
Sponsor
Alzheimer's Disease Cooperative Study (ADCS)
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 55 Years to 90 Years
Official registry ID
NCT00071721
Official title
A Randomized, Double-Blind, Placebo-Controlled Trial of Valproate to Attenuate the Progression of Alzheimer's Disease (AD)

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00071721. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 46 sites
  • Sun Health Research Institute
    Sun City, Arizona
    Site status: Not listed — confirm with the team
  • University of Arizona
    Tucson, Arizona
    Site status: Not listed — confirm with the team
  • University of California, Irvine
    Irvine, California
    Site status: Not listed — confirm with the team
  • University of California, ADRC, San Diego
    La Jolla, California
    Site status: Not listed — confirm with the team
  • VA Healthcare System Long Beach
    Long Beach, California
    Site status: Not listed — confirm with the team
  • University of Southern California
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • University of California ADRC
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • University of California, LA (Olive View)
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • Pacific Research Network
    San Diego, California
    Site status: Not listed — confirm with the team
  • Stanford University, VA Aging Clinical Research Center
    Stanford, California
    Site status: Not listed — confirm with the team
  • Yale University School of Medicine
    New Haven, Connecticut
    Site status: Not listed — confirm with the team
  • Georgetown University Medical Center
    Washington D.C., District of Columbia
    Site status: Not listed — confirm with the team
  • Howard University
    Washington D.C., District of Columbia
    Site status: Not listed — confirm with the team
  • Mayo Clinic
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Wein Center, Mount Sinai Medical Center
    Miami, Florida
    Site status: Not listed — confirm with the team
  • University of South Florida
    Tampa, Florida
    Site status: Not listed — confirm with the team
  • Byrd Institute
    Tampa, Florida
    Site status: Not listed — confirm with the team
  • Premier Research Institute
    West Palm Beach, Florida
    Site status: Not listed — confirm with the team
  • Emory University
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Northwestern University
    Chicago, Illinois
    Site status: Not listed — confirm with the team
  • Southern Illinois University
    Springfield, Illinois
    Site status: Not listed — confirm with the team
  • Indiana University School of Medicine
    Indianapolis, Indiana
    Site status: Not listed — confirm with the team
  • University of Kansas
    Kansas City, Kansas
    Site status: Not listed — confirm with the team
  • Lahey Clinic, Research Neurology
    Burlington, Massachusetts
    Site status: Not listed — confirm with the team
  • University of Michigan
    Ann Arbor, Michigan
    Site status: Not listed — confirm with the team
  • Saint Mary's Health Care
    Grand Rapids, Michigan
    Site status: Not listed — confirm with the team
  • St. Louis University
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • University of Nevada
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Albany Medical Center
    Albany, New York
    Site status: Not listed — confirm with the team
  • Dent Neurologic Institute
    Amherst, New York
    Site status: Not listed — confirm with the team
  • New York University Medical Center
    New York, New York
    Site status: Not listed — confirm with the team
  • Columbia University
    New York, New York
    Site status: Not listed — confirm with the team
  • Global Research and Consulting
    Olean, New York
    Site status: Not listed — confirm with the team
  • University of Rochester
    Rochester, New York
    Site status: Not listed — confirm with the team
  • Syracuse VA Medical Center
    Syracuse, New York
    Site status: Not listed — confirm with the team
  • North East Ohio Health Services
    Beachwood, Ohio
    Site status: Not listed — confirm with the team
  • Case Western Reserve University, University Hospitals of Cleveland
    Cleveland, Ohio
    Site status: Not listed — confirm with the team
  • University of Pennsylvania
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Brown University, Memorial Hospital of Rhode Island
    Providence, Rhode Island
    Site status: Not listed — confirm with the team
  • Medical University of South Carolina-Columbia
    Columbia, South Carolina
    Site status: Not listed — confirm with the team
  • Medical University of South Carolina-Florence
    Florence, South Carolina
    Site status: Not listed — confirm with the team
  • Medical University of South Carolina
    North Charleston, South Carolina
    Site status: Not listed — confirm with the team
  • Psychiatric Consultants
    Nashville, Tennessee
    Site status: Not listed — confirm with the team
  • University of Texas Southwestern Medical Center
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Southwestern Vermont Medical Center
    Bennington, Vermont
    Site status: Not listed — confirm with the team
  • University of Virginia
    Charlottesville, Virginia
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Valproate, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 55 Years to 90 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Alzheimer's Disease Cooperative Study (ADCS), which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.